Virpax Pharmaceuticals In... (VRPX)
undefined
undefined%
At close: undefined
0.36
-11.00%
Pre-market Dec 16, 2024, 07:52 AM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Net Income -15.19M -21.65M -12.06M -4.34M -3.31M -2.64M
Depreciation & Amortization - - - - - -
Stock-Based Compensation 544.77K 745.03K 974.23K 1.47M 678.15K 384.95K
Other Working Capital 4.19M 4.05M -2.71M -13.09K 7.95K -13.13K
Other Non-Cash Items 599.43K 745.03K -61.82K 153.22K 564.64K 14.98K
Deferred Income Tax - - - - - -
Change in Working Capital 4.19M 3.06M -3.40M 1.33M 931.89K 441.37K
Operating Cash Flow -9.85M -17.85M -14.54M -1.38M -1.13M -1.80M
Capital Expenditures - - - - - -
Acquisitions - - - - - -
Purchase of Investments - - - - - -
Sales Maturities Of Investments - - - - - -
Other Investing Acitivies - - - - - -
Investing Cash Flow - - - - - -
Debt Repayment - - -1.50M 72.10K 500.00K 554.77K
Common Stock Repurchased - - - - - -
Dividend Paid - - - - - -
Other Financial Acitivies - - -5.19M -50.88K 625.00K -
Financial Cash Flow - - 51.33M 1.40M 1.13M 1.67M
Net Cash Flow -9.85M -17.85M 36.79M 13.26K -6.83K -124.87K
Free Cash Flow -9.85M -17.85M -14.54M -1.38M -1.13M -1.80M